These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 26967209)
1. Spatial Navigation in Preclinical Alzheimer's Disease. Allison SL; Fagan AM; Morris JC; Head D J Alzheimers Dis; 2016 Feb; 52(1):77-90. PubMed ID: 26967209 [TBL] [Abstract][Full Text] [Related]
2. Developing a Spatial Navigation Screening Tool Sensitive to the Preclinical Alzheimer Disease Continuum. Allison SL; Rodebaugh TL; Johnston C; Fagan AM; Morris JC; Head D Arch Clin Neuropsychol; 2019 Oct; 34(7):1138-1155. PubMed ID: 31197326 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease. Antonell A; Mansilla A; Rami L; Lladó A; Iranzo A; Olives J; Balasa M; Sánchez-Valle R; Molinuevo JL J Alzheimers Dis; 2014; 42(3):901-8. PubMed ID: 25024322 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies. Bousiges O; Cretin B; Lavaux T; Philippi N; Jung B; Hezard S; Heitz C; Demuynck C; Gabel A; Martin-Hunyadi C; Blanc F J Alzheimers Dis; 2016; 51(4):1069-83. PubMed ID: 26923009 [TBL] [Abstract][Full Text] [Related]
5. Linking CSF and cognition in Alzheimer's disease: Reanalysis of clinical data. Guhra M; Thomas C; Boedeker S; Kreisel S; Driessen M; Beblo T; Ohrmann P; Toepper M Exp Gerontol; 2016 Jan; 73():107-13. PubMed ID: 26585048 [TBL] [Abstract][Full Text] [Related]
6. Different Profiles of Spatial Navigation Deficits In Alzheimer's Disease Biomarker-Positive Versus Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment. Laczó M; Martinkovic L; Lerch O; Wiener JM; Kalinova J; Matuskova V; Nedelska Z; Vyhnalek M; Hort J; Laczó J Front Aging Neurosci; 2022; 14():886778. PubMed ID: 35721017 [TBL] [Abstract][Full Text] [Related]
7. The effect of Alzheimer's disease on spatial navigation strategies. Parizkova M; Lerch O; Moffat SD; Andel R; Mazancova AF; Nedelska Z; Vyhnalek M; Hort J; Laczó J Neurobiol Aging; 2018 Apr; 64():107-115. PubMed ID: 29358117 [TBL] [Abstract][Full Text] [Related]
8. Alzheimer disease biomarkers are associated with decline in subjective memory, attention, and spatial navigation ability in clinically normal adults. Levine TF; Dessenberger SJ; Allison SL; Head D; J Int Neuropsychol Soc; 2024 May; 30(4):313-327. PubMed ID: 38014546 [TBL] [Abstract][Full Text] [Related]
9. Spatial navigation in normal aging and the prodromal stage of Alzheimer's disease: insights from imaging and behavioral studies. Lithfous S; Dufour A; Després O Ageing Res Rev; 2013 Jan; 12(1):201-13. PubMed ID: 22771718 [TBL] [Abstract][Full Text] [Related]
10. Virtual reality as allocentric/egocentric technology for the assessment of cognitive decline in the elderly. Morganti F; Riva G Stud Health Technol Inform; 2014; 196():278-84. PubMed ID: 24732522 [TBL] [Abstract][Full Text] [Related]
11. Limited Longitudinal Change in Self-reported Spatial Navigation Ability in Preclinical Alzheimer Disease. Levine TF; Roe CM; Babulal GM; Fagan AM; Head D Alzheimer Dis Assoc Disord; 2022 Jan-Mar 01; 36(1):15-21. PubMed ID: 34966024 [TBL] [Abstract][Full Text] [Related]
12. Preclinical AD predicts decline in memory and executive functions in subjective complaints. van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134 [TBL] [Abstract][Full Text] [Related]
13. Alzheimer Disease Biomarkers and Driving in Clinically Normal Older Adults: Role of Spatial Navigation Abilities. Allison S; Babulal GM; Stout SH; Barco PP; Carr DB; Fagan AM; Morris JC; Roe CM; Head D Alzheimer Dis Assoc Disord; 2018; 32(2):101-106. PubMed ID: 29578861 [TBL] [Abstract][Full Text] [Related]
15. Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults. Pettigrew C; Soldan A; Moghekar A; Wang MC; Gross AL; O'Brien R; Albert M Neuropsychologia; 2015 Nov; 78():63-72. PubMed ID: 26394023 [TBL] [Abstract][Full Text] [Related]
16. From allo- to egocentric spatial ability in early Alzheimer's disease: a study with virtual reality spatial tasks. Morganti F; Stefanini S; Riva G Cogn Neurosci; 2013; 4(3-4):171-80. PubMed ID: 24251605 [TBL] [Abstract][Full Text] [Related]
17. Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease. Thordardottir S; Ståhlbom AK; Ferreira D; Almkvist O; Westman E; Zetterberg H; Eriksdotter M; Blennow K; Graff C J Alzheimers Dis; 2015; 43(4):1393-402. PubMed ID: 25182737 [TBL] [Abstract][Full Text] [Related]
18. Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease. Alcolea D; Martínez-Lage P; Sánchez-Juan P; Olazarán J; Antúnez C; Izagirre A; Ecay-Torres M; Estanga A; Clerigué M; Guisasola MC; Sánchez Ruiz D; Marín Muñoz J; Calero M; Blesa R; Clarimón J; Carmona-Iragui M; Morenas-Rodríguez E; Rodríguez-Rodríguez E; Vázquez Higuera JL; Fortea J; Lleó A Neurology; 2015 Aug; 85(7):626-33. PubMed ID: 26180139 [TBL] [Abstract][Full Text] [Related]
19. Age effects on wayfinding and route learning skills. Head D; Isom M Behav Brain Res; 2010 May; 209(1):49-58. PubMed ID: 20085784 [TBL] [Abstract][Full Text] [Related]
20. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease. Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]